Lindbrook Capital’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $3.39K | Sell |
276
-268
| -49% | -$3.29K | ﹤0.01% | 2106 |
|
|
2024
Q4 | $7.19K | Sell |
544
-172
| -24% | -$2.27K | ﹤0.01% | 1817 |
|
|
2024
Q3 | $13.8K | Sell |
716
-63
| -8% | -$1.21K | ﹤0.01% | 1508 |
|
|
2024
Q2 | $16K | Sell |
779
-23
| -3% | -$472 | ﹤0.01% | 1375 |
|
|
2024
Q1 | $19.1K | Buy |
802
+46
| +6% | +$1.1K | ﹤0.01% | 1239 |
|
|
2023
Q4 | $16.3K | Buy |
756
+661
| +696% | +$14.3K | ﹤0.01% | 1306 |
|
|
2023
Q3 | $1.38K | Buy |
95
+20
| +27% | +$290 | ﹤0.01% | 2256 |
|
|
2023
Q2 | $1.57K | Sell |
75
-124
| -62% | -$2.6K | ﹤0.01% | 2242 |
|
|
2023
Q1 | $4.2K | Buy |
199
+104
| +109% | +$2.2K | ﹤0.01% | 1923 |
|
|
2022
Q4 | $2.42K | Sell |
95
-164
| -63% | -$4.17K | ﹤0.01% | 2162 |
|
|
2022
Q3 | $6K | Buy |
259
+224
| +640% | +$5.19K | ﹤0.01% | 1594 |
|
|
2022
Q2 | $1K | Buy |
+35
| New | +$1K | ﹤0.01% | 2361 |
|